Purchase, storage and delivery of live attenuated vaccine against lumpy skin disease

closed

— The purchase of maximum 1 800 000 doses of live attenuated vaccine against LSD. This will be executed with one initial purchase of 300 000 doses and up to five (5) replenishments, of maximum 300.000 doses each, upon request from the Commission, — The storage of a stock of 300 000 doses, readily available for delivery to any of the destinations listed in the technical specifications, that can be replaced, if depleted, partially or totally, up to 5 times until the end of the contract, upon request from the Commission, — The timely delivery of maximum 1.800.000 doses divided in as many consignments as needed to any of the destinations listed in the technical specifiations, — The storage of any vaccines in stock at the end of the contract for the remainder of their shelf life, — The proper destruction and disposal of any unused vaccine at the end of its shelf life.